| 靶点: |
IC50: 2.36 μM (RXFP3), 7.82 μM (ERK1 phosphorylation), 13.86 μM (ERK2 phosphorylation) |
| 体内研究: |
RLX-33 (10 mg/kg; IP, single dosage) attenuates the RXFP3-selective agonist R3/I5-induced increase in feeding in male Wistar rats. RLX-33 (10 mg/kg; IP, single dosage) exhibits a good brain penetration and highly protein-bound in rats plasma. Pharmacokinetic Parameters of RLX-33 in male Wistar rats (IP, 10 mg/kg). |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.16 ml |
10.802 ml |
21.603 ml |
| 5 mM |
0.432 ml |
2.16 ml |
4.321 ml |
| 10 mM |
0.216 ml |
1.08 ml |
2.16 ml |
| 50 mM |
0.043 ml |
0.216 ml |
0.432 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |